Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lp(A)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Post-approval studies (Phase 4)Study completedNCT07792512
What this trial is testing

Efficacy of Aloe Vera Compared to Corticosteroid in Topical Treatment of Oral Lichen Planus and on Salivary Levels of Tumor Necrosis Factor Alpha

Who this might be right for
Oral Lichen PlanusTumor Necrosis Factor-alpha
Ain Shams University 24
Not applicableStudy completedNCT03172611
What this trial is testing

A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles

Who this might be right for
Hypercholesterolemia
Texas Woman's University 33
Not applicableNo Longer AvailableNCT07560709
What this trial is testing

Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma

Who this might be right for
Recurrent Osteosarcoma
University of Florida
Large-scale testing (Phase 3)Looking for participantsNCT06875973
What this trial is testing

Pelacarsen Roll-over Extension Program

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 599
Early research (Phase 1)Looking for participantsNCT06980428
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Who this might be right for
Healthy ParticipantsDyslipidemia
AstraZeneca 136
Not applicableNot Yet RecruitingNCT07737444
What this trial is testing

Association of Lipoprotein(a) With Postoperative Atrial Fibrillation

Who this might be right for
POAFAtrial Fibrillation (AF)
Anthony Tang 20
Testing effectiveness (Phase 2)Looking for participantsNCT06496243
What this trial is testing

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

Who this might be right for
Dyslipidemias
NewAmsterdam Pharma 69
Large-scale testing (Phase 3)Study completedNCT06267560
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 422
Not applicableStudy completedNCT05489120
What this trial is testing

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease Stage 3BChronic Kidney Disease stage4Chronic Kidney Disease Stage 5+1 more
Dr. Schär AG / SPA 210
Large-scale testing (Phase 3)Looking for participantsNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Large-scale testing (Phase 3)Study completedNCT04023552
What this trial is testing

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 8,323
Not applicableNot Yet RecruitingNCT07198009
What this trial is testing

2-HOBA Supplementation in People With Elevated Lipoprotein(a)

Who this might be right for
HyperlipidemiaElevated Lp(a)
The Miriam Hospital 10
Not applicableStudy completedNCT04247048
What this trial is testing

Kinetic Study of Lp(a) and PCSK9 in Humans

Who this might be right for
Cholesterol; Metabolic DisorderLipoproteinemia
Nantes University Hospital 21
Not applicableStudy completedNCT00853775
What this trial is testing

Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups

Who this might be right for
HealthyHeart Disease
University of California, Davis 325
Early research (Phase 1)Study completedNCT01711723
What this trial is testing

Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment

Who this might be right for
Atherosclerosis
GlaxoSmithKline 16
Not applicableStudy completedNCT06156839
What this trial is testing

Junior LP Foot - Clinical Investigation Protocol

Who this might be right for
Amputation
Össur Iceland ehf 13
Large-scale testing (Phase 3)Ended earlyNCT00562016
What this trial is testing

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Who this might be right for
Coronary Artery Disease
Abiomed Inc. 452
Not applicableUnknownNCT03416595
What this trial is testing

A Study on Efficacy of Feeding N1115 Probiotic Supplement to Young Children

Who this might be right for
Intestinal Growth of Young Children
Junlebao Dairy Group Co., Ltd. 60
Not applicableLooking for participantsNCT07478887
What this trial is testing

Impact of the Corrie Lipids Digital Health Program on Lipid Optimization

Who this might be right for
Cardiovascular RiskLDL-CLipids+2 more
Johns Hopkins University 1,000
Next Page